ID   CBR4_RAT                Reviewed;         236 AA.
AC   Q7TS56;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   29-MAY-2024, entry version 128.
DE   RecName: Full=3-oxoacyl-[acyl-carrier-protein] reductase;
DE            EC=1.1.1.100 {ECO:0000250|UniProtKB:Q8N4T8};
DE   AltName: Full=3-ketoacyl-[acyl-carrier-protein] reductase beta subunit {ECO:0000250|UniProtKB:Q8N4T8};
DE            Short=KAR beta subunit {ECO:0000250|UniProtKB:Q8N4T8};
DE   AltName: Full=Carbonyl reductase family member 4;
DE            Short=CBR4;
DE   AltName: Full=Quinone reductase CBR4;
DE            EC=1.6.5.10 {ECO:0000250|UniProtKB:Q8N4T8};
GN   Name=Cbr4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Deng Q., Guo J.H.;
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Component of the heterotetramer complex KAR (3-ketoacyl-[acyl
CC       carrier protein] reductase or 3-ketoacyl-[ACP] reductase) that forms
CC       part of the mitochondrial fatty acid synthase (mtFAS). Beta-subunit of
CC       the KAR heterotetramer complex, responsible for the 3-ketoacyl-ACP
CC       reductase activity of the mtFAS, reduces 3-oxoacyl-[ACP] to (3R)-
CC       hydroxyacyl-[ACP] in a NADPH-dependent manner with no chain length
CC       preference, thereby participating in mitochondrial fatty acid
CC       biosynthesis. The homotetramer has NADPH-dependent quinone reductase
CC       activity (in vitro), hence could play a role in protection against
CC       cytotoxicity of exogenous quinones. As a heterotetramer, it can also
CC       reduce 9,10-phenanthrenequinone, 1,4-benzoquinone and various other o-
CC       quinones and p-quinones (in vitro). {ECO:0000250|UniProtKB:Q8N4T8}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a (3R)-hydroxyacyl-[ACP] + NADP(+) = a 3-oxoacyl-[ACP] + H(+)
CC         + NADPH; Xref=Rhea:RHEA:17397, Rhea:RHEA-COMP:9916, Rhea:RHEA-
CC         COMP:9945, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:78776, ChEBI:CHEBI:78827; EC=1.1.1.100;
CC         Evidence={ECO:0000250|UniProtKB:Q8N4T8};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:17399;
CC         Evidence={ECO:0000250|UniProtKB:Q8N4T8};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADPH = a quinol + NADP(+);
CC         Xref=Rhea:RHEA:46164, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:132124;
CC         EC=1.6.5.10; Evidence={ECO:0000250|UniProtKB:Q8N4T8};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46165;
CC         Evidence={ECO:0000250|UniProtKB:Q8N4T8};
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC       {ECO:0000250|UniProtKB:Q8N4T8}.
CC   -!- SUBUNIT: Homotetramer (in vitro). Heterotetramer with HSD17B8; contains
CC       two molecules each of HSD17B8 and CBR4. Does not form homotetramers
CC       when HSD17B8 is coexpressed, only heterotetramers (in vitro).
CC       {ECO:0000250|UniProtKB:Q8N4T8}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000250|UniProtKB:Q8N4T8}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY305858; AAP70488.1; -; mRNA.
DR   EMBL; BC086378; AAH86378.1; -; mRNA.
DR   RefSeq; NP_872613.1; NM_182672.2.
DR   AlphaFoldDB; Q7TS56; -.
DR   SMR; Q7TS56; -.
DR   STRING; 10116.ENSRNOP00000038351; -.
DR   iPTMnet; Q7TS56; -.
DR   PhosphoSitePlus; Q7TS56; -.
DR   PaxDb; 10116-ENSRNOP00000038351; -.
DR   Ensembl; ENSRNOT00000032199.7; ENSRNOP00000038351.6; ENSRNOG00000024411.7.
DR   Ensembl; ENSRNOT00055022547; ENSRNOP00055018314; ENSRNOG00055013156.
DR   Ensembl; ENSRNOT00060025658; ENSRNOP00060020485; ENSRNOG00060014978.
DR   Ensembl; ENSRNOT00065006019; ENSRNOP00065004306; ENSRNOG00065004127.
DR   GeneID; 359725; -.
DR   KEGG; rno:359725; -.
DR   UCSC; RGD:727826; rat.
DR   AGR; RGD:727826; -.
DR   CTD; 84869; -.
DR   RGD; 727826; Cbr4.
DR   eggNOG; KOG1200; Eukaryota.
DR   GeneTree; ENSGT00940000157620; -.
DR   HOGENOM; CLU_010194_1_3_1; -.
DR   InParanoid; Q7TS56; -.
DR   OMA; CQKHMVD; -.
DR   OrthoDB; 5478123at2759; -.
DR   PhylomeDB; Q7TS56; -.
DR   Reactome; R-RNO-75105; Fatty acyl-CoA biosynthesis.
DR   UniPathway; UPA00094; -.
DR   PRO; PR:Q7TS56; -.
DR   Proteomes; UP000002494; Chromosome 16.
DR   Bgee; ENSRNOG00000024411; Expressed in liver and 20 other cell types or tissues.
DR   GO; GO:0005759; C:mitochondrial matrix; ISS:UniProtKB.
DR   GO; GO:1990204; C:oxidoreductase complex; ISS:UniProtKB.
DR   GO; GO:0004316; F:3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; ISS:UniProtKB.
DR   GO; GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; ISO:RGD.
DR   GO; GO:0070402; F:NADPH binding; ISS:UniProtKB.
DR   GO; GO:0008753; F:NADPH dehydrogenase (quinone) activity; ISS:UniProtKB.
DR   GO; GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IBA:GO_Central.
DR   GO; GO:0048038; F:quinone binding; ISS:UniProtKB.
DR   GO; GO:0044597; P:daunorubicin metabolic process; ISO:RGD.
DR   GO; GO:0044598; P:doxorubicin metabolic process; ISO:RGD.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0051290; P:protein heterotetramerization; ISS:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; ISO:RGD.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   PANTHER; PTHR42760:SF40; 3-OXOACYL-[ACYL-CARRIER-PROTEIN] REDUCTASE; 1.
DR   PANTHER; PTHR42760; SHORT-CHAIN DEHYDROGENASES/REDUCTASES FAMILY MEMBER; 1.
DR   Pfam; PF13561; adh_short_C2; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SMART; SM00822; PKS_KR; 1.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Lipid biosynthesis; Lipid metabolism; Mitochondrion; NAD; NADP;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN           1..236
FT                   /note="3-oxoacyl-[acyl-carrier-protein] reductase"
FT                   /id="PRO_0000319880"
FT   ACT_SITE        147
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10001"
FT   BINDING         11..14
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N4T8"
FT   BINDING         34..35
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N4T8"
FT   BINDING         83..85
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N4T8"
FT   BINDING         134
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N4T8"
FT   BINDING         147
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N4T8"
FT   BINDING         151
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N4T8"
FT   BINDING         180..182
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N4T8"
FT   SITE            168
FT                   /note="Important for interaction with acyl carrier protein
FT                   (ACP)"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N4T8"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N4T8"
FT   MOD_RES         40
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91VT4"
FT   MOD_RES         96
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91VT4"
FT   MOD_RES         194
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91VT4"
SQ   SEQUENCE   236 AA;  25287 MW;  3223506C39975316 CRC64;
     MDKVCAVFGG SRGIGKAVAQ LMAQKGYRLA IVARNLEVAK ATASELGGIH LAFRCNIAKE
     GDVHSTFEEM EKHLGPVNFL VNAAGINRDS LLVRTKTEDM LSQLHTNLLG TMLTCRAAMR
     TMIQQGGSIV NVGSIIGLKG NVGQAAYSAT KGGLIGFSRS LAKEVARKKI RVNVVAPGFI
     HTDMTKHLKE EHFKKNIPLG RFGEALEVAH AVVFLLESPY ITGHVLIVDG GLQLTA
//
